{"id":18128,"date":"2026-05-15T15:06:09","date_gmt":"2026-05-15T07:06:09","guid":{"rendered":"https:\/\/y2nbc5qg9c-staging.wpdns.site\/u-neuron-launches-exosome-rd-pilot-manufacturing-center-to-capture-multi-billion-exosome-market-opportunities\/"},"modified":"2026-10-22T15:22:14","modified_gmt":"2026-10-22T07:22:14","slug":"u-neuron-launches-exosome-rd-pilot-manufacturing-center-to-capture-multi-billion-exosome-market-opportunities","status":"publish","type":"post","link":"https:\/\/u-neuron.com\/en\/u-neuron-launches-exosome-rd-pilot-manufacturing-center-to-capture-multi-billion-exosome-market-opportunities\/","title":{"rendered":"U-NEURON Launches Exosome R&#038;D Pilot Manufacturing Center to Capture Multi-Billion Exosome Market Opportunities"},"content":{"rendered":"&#13;\n<p class=\"wp-block-paragraph\">Economic Daily News \/ Reporter Po-Hong Hsieh\nU-NEURON (6973) held an inauguration ceremony on the 12th at the Hsinchu Biomedical Science Park for its Exosome R&amp;D Pilot Manufacturing Center, launching the company\u2019s first professional one-stop R&amp;D and manufacturing base integrating exosome research, production, efficacy validation, and translational applications to unlock new market opportunities in regenerative aesthetics, skincare, and healthcare industries.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">Yonglirong<a href=\"https:\/\/money.udn.com\/industry\/company\/6973\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">The event brought together over one hundred key figures, including Deputy Minister of Economic Affairs Ho Chin-tsang, Hsinchu Science Park Bureau Deputy Director-General Yuh Ching-chiou, Development Center for Biotechnology CEO Tsai-Kun Li, Director-General of the Biotechnology and Pharmaceutical Industries Promotion Office Chien-Yueh Huang, and Chlitina Marketing Taiwan Branch General Manager Chen Bai-ying. Attendees witnessed a significant milestone signifying Taiwan\u2019s autonomous innovation capabilities in amniotic fluid stem cell and exosome application technologies as they transition into scalable mass production and commercialization.<\/a> On the 12th, the opening ceremony of the exosome research and development pilot manufacturing center was held in Zhubei Biomedical Park, launching the company&#8217;s first one-stop professional research and development base that integrates exosome research and development, manufacturing, efficacy verification and application transformation, opening a new blue ocean for the regenerative medical beauty care and health care industry.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">Positioned as a regenerative medicine stem cell and exosome company, U-NEURON leverages amniotic fluid stem cells at its core to advance stem cell and exosome drug candidates for erectile dysfunction and dry eye syndrome. The company is further expanding the application of deer-derived exosomes\u2014including deer amniotic fluid and velvet antler\u2014extending into high-value markets such as regenerative aesthetics, skincare ingredients, and medical devices. Additionally, U-NEURON developed the ACT.A velvet antler polypeptide revitalizing factor for functional foods, demonstrating its multi-dimensional product pipeline capabilities.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">Dr. Hsiao-Min Huang, President and Chief Technology Officer of U-NEURON, stated that the Exosome R&amp;D Pilot Manufacturing Center has implemented GMP-grade production and quality control systems with a monthly capacity of up to 200,000 doses. The center can process exosome sources derived from human amniotic fluid, deer amniotic fluid, velvet antler, and other animal, plant, and microbial origins.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">He noted that the center provides one-stop services tailored to different product applications, target markets, and regulatory requirements, spanning raw material preparation, custom formulation development, efficacy validation, regulatory consulting, and international OEM\/ODM services. These offerings apply broadly across high-value sectors such as regenerative aesthetics, functional nutraceuticals, and medical devices, ensuring products meet stringent international standards in quality, safety, and compliance.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">The center also serves as a crucial R&amp;D and manufacturing hub for U-NEURON\u2019s international partnerships and commercial strategy, establishing a solid foundation for expanding into global high-end regenerative tech aesthetics and wellness markets.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">During the inauguration ceremony, U-NEURON concurrently launched its proprietary &#8220;Exosome Design House&#8221; service platform. Centered on R&amp;D capabilities, the platform combines a comprehensive database with AI technology to rapidly design functional exosome formulations, helping clients develop customized products within minimal timelines. This differentiated service delivers a Total Solution framework, accelerating order acquisition, shortening time-to-market, and significantly enhancing client competitiveness and market responsiveness.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">U-NEURON Chairman Dr. Frank Chien stated that the company has formally embedded the &#8220;Exosome Design House&#8221; concept and culture into its operational strategy. By focusing on R&amp;D design and technology integration, U-NEURON provides clients with a Total Solution spanning product planning and formulation development to market execution. This model emphasizes maximizing commercial value with minimal capital expenditure, leveraging integrated R&amp;D and design capabilities to strengthen enterprise competitiveness and customer retention, fulfilling the core philosophy of client-oriented, differentiated operations.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">At the execution level, U-NEURON positions the Design House as its core to develop and manufacture functional exosome raw materials, while outsourcing final production steps to specialized cosmetic and food manufacturing facilities (analogous to OSAT packaging and testing plants in the semiconductor industry) to lower capital investment in self-built capacity. Moving forward, the company expects capital expenditures to remain low while continuously maximizing commercial value through innovative design and patented technologies.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">According to a Grand View Research report, the global exosome market is projected to expand from approximately $177 million in 2024 at a compound annual growth rate (CAGR) of 28.7% starting in 2025, reaching $794 million by 2030. This growth momentum stems from the rising prevalence of chronic diseases and demand for precision healthcare, while exosome applications in high-performance skincare and regenerative aesthetics serve as key drivers of market expansion.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">U-NEURON\u2019s recent inauguration of its Exosome R&amp;D Pilot Manufacturing Center and Exosome Design House platform combines GMP-grade capacity with AI formulation design capabilities to deliver one-stop solutions spanning raw material preparation, formulation development, efficacy validation, and OEM\/ODM across diverse markets and regulatory environments. This strategic positioning enables U-NEURON to secure an early advantage in the high-performance exosome skincare market and become a key partner for international brands developing regenerative aesthetics and skincare products.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">Looking ahead to 2025, U-NEURON will drive operations through the dual axes of &#8220;Regenerative Medicine \u00d7 Exosome Technology.&#8221; Alongside advancing clinical development for its male erectile dysfunction drug candidate UA002, the company will continue expanding its global footprint in exosome skincare and functional foods, deepening partnerships with international brands and distribution channels.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">U-NEURON emphasized that it seeks to serve not only as a raw material and manufacturing supplier, but also as an innovation design think tank for exosome skincare. Utilizing a &#8220;Commercial Monetization \u00d7 R&amp;D Reinvestment&#8221; model to penetrate global markets, U-NEURON aims to become a leading technology provider in Asia&#8217;s regenerative aesthetics and high-end skincare sectors.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">U-NEURON inaugurated its &#8220;Exosome R&amp;D Pilot Manufacturing Center&#8221; at the Hsinchu Biomedical Science Park on the 12th. Photo \/ Po-Hong Hsieh<\/p>&#13;\n&#13;\n<figure class=\"wp-block-image\"><a href=\"https:\/\/pgw.udn.com.tw\/gw\/photo.php?u=https:\/\/uc.udn.com.tw\/photo\/2025\/08\/12\/realtime\/32884430.jpg&amp;x=0&amp;y=0&amp;sw=0&amp;sh=0&amp;sl=W&amp;fw=1050&amp;exp=3600&amp;exp=3600\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" title=\"On the 12th, Yonglirong opened the &quot;Exosome Research and Leading Manufacturing Center&quot; in Zhubei Health District Park. Reporter Xie Baihong\/Photography\" src=\"https:\/\/pgw.udn.com.tw\/gw\/photo.php?u=https:\/\/uc.udn.com.tw\/photo\/2025\/08\/12\/realtime\/32884430.jpg&amp;x=0&amp;y=0&amp;sw=0&amp;sh=0&amp;sl=W&amp;fw=1050&amp;exp=3600&amp;exp=3600\" alt=\"On the 12th, Yonglirong opened the &quot;Exosome Research and Leading Manufacturing Center&quot; in Zhubei Health District Park. Reporter Xie Baihong\/Photography\"\/><\/a>&#13;\n<figcaption class=\"wp-element-caption\">On the 12th, Yonglirong opened the &#8220;Exosome Research and Leading Manufacturing Center&#8221; in Zhubei Health District Park. Reporter Xie Baihong\/Photography<\/figcaption>&#13;\n<\/figure>&#13;\n\r\n<figure class=\"wp-block-embed\">\r\n<div class=\"wp-block-embed__wrapper\">https:\/\/money.udn.com\/money\/story\/5612\/8933548?from=edn_newestlist_rank<\/div>\r\n<\/figure>\r\n","protected":false},"excerpt":{"rendered":"<p>Economic Daily News \/ Reporter Po-Hong Hsieh<\/p>\n","protected":false},"author":15,"featured_media":18129,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[235,240,239,236,242],"tags":[],"class_list":["post-18128","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-investor-zone","category-event-and-exhibition-information","category-latest-news","category-media-reports","category-technology-platform-and-rd"],"acf":[],"_links":{"self":[{"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/posts\/18128","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/comments?post=18128"}],"version-history":[{"count":3,"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/posts\/18128\/revisions"}],"predecessor-version":[{"id":18235,"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/posts\/18128\/revisions\/18235"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/media\/18129"}],"wp:attachment":[{"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/media?parent=18128"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/categories?post=18128"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/tags?post=18128"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}